Detection of obstructive coronary artery disease using regadenoson stress and 82Rb PET/CT myocardial perfusion imaging

Journal of Nuclear Medicine

Volumn 54, Issue 10, 2013, Pages 1748-1754

  Hsiao, Edward ^a   Ali, Bilal ^a   Blankstein, Ron ^a   Skali, Hicham ^a   Ali, Towhid ^a   Bruyere Jr , John ^a   Kwong, Raymond Y ^a   Di Carli, Marcelo F ^a   Dorbala, Sharmila ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Coronary angiography; Diagnostic accuracy; Ejection fraction; Regadenoson

Indexed keywords

REGADENOSON; RUBIDIUM 82; PURINE DERIVATIVE; PYRAZOLE DERIVATIVE; RUBIDIUM; VASODILATOR AGENT; DIAGNOSTIC AGENT;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; COHORT ANALYSIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; DUKE SCORE; EXERCISE TEST; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL PERFUSION IMAGING; PET-CT SCANNER; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; WHOLE BODY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; DRUG EFFECTS; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; MIDDLE AGED; MULTIMODAL IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGICAL STRESS; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; SCINTISCANNING; DRUG EFFECT; HEART EJECTION FRACTION;

AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; HUMANS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; MYOCARDIAL PERFUSION IMAGING; POSITRON-EMISSION TOMOGRAPHY; PURINES; PYRAZOLES; RUBIDIUM RADIOISOTOPES; STRESS, PHYSIOLOGICAL; STROKE VOLUME; TOMOGRAPHY, X-RAY COMPUTED; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION, LEFT;

82RB; CORONARY ANGIOGRAPHY; DIAGNOSTIC ACCURACY; EJECTION FRACTION; REGADENOSON;

EID: 84891713756     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.113.120063     Document Type: Article

References (27)

1. Cerqueira MD, Nguyen P, Staehr P, Underwood SR, Iskandrian AE. Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results. JACC Cardiovasc Imaging. 2008;1:307-316.
2. Iskandrian AE, Bateman TM, Belardinelli L, et al. Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol. 2007;14:645-658.
3. Mahmarian JJ, Cerqueira MD, Iskandrian AE, et al. Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial. JACC Cardiovasc Imaging. 2009;2:959-968.
4. Lieu HD, Shryock JC, von Mering GO, et al. Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans. J Nucl Cardiol. 2007;14:514-520.
5. Di Carli MF, Hachamovitch R. New technology for noninvasive evaluation of coronary artery disease. Circulation. 2007;115:1464-1480.
6. Gould KL, Goldstein RA, Mullani NA, et al. Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. VIII. Clinical feasibility of positron cardiac imaging without a cyclotron using generator-produced rubidium-82. J Am Coll Cardiol. 1986;7: 775-789.
7. Grover-McKay M, Ratib O, Schwaiger M, et al. Detection of coronary artery disease with positron emission tomography and rubidium 82. Am Heart J. 1992; 123:646-652.
8. Bateman TM, Heller GV, McGhie AI, et al. Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: comparison with ECG-gated Tc-99m sestamibi SPECT. J Nucl Cardiol. 2006;13:24-33.
9. Demer LL, Gould KL, Goldstein RA, et al. Assessment of coronary artery disease severity by positron emission tomography: comparison with quantitative arteriography in 193 patients. Circulation. 1989;79:825-835.
10. Go RT, Marwick TH, MacIntyre WJ, et al. A prospective comparison of rubidium-82 PET and thallium-201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease. J Nucl Med. 1990;31:1899-1905.
11. Stewart RE, Schwaiger M, Molina E, et al. Comparison of rubidium-82 positron emission tomography and thallium-201 SPECT imaging for detection of coronary artery disease. Am J Cardiol. 1991;67:1303-1310.
12. Sampson UK, Dorbala S, Limaye A, Kwong R, Di Carli MF. Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease. J Am Coll Cardiol. 2007;49:1052-1058.
13. Mekkaoui C, Jadbabaie F, Dione DP, et al. Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics. JACC Cardiovasc Imaging. 2009;2:1198-1208.
14. Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina: summary article-a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients with Chronic Stable Angina). J Am Coll Cardiol. 2003;41:159-168.
15. 82Rb. J Nucl Med. 2010;51:1592-1599.
16. Califf RM, Phillips HR, Hindman MC, et al. Prognostic value of a coronary artery jeopardy score. J Am Coll Cardiol. 1985;5:1055-1063.
17. 82Rb myocardial perfusion PET. Eur J Nucl Med Mol Imaging. 2011;38:1908-1916.
18. Kajander S, Joutsiniemi E, Saraste M, et al. Cardiac positron emission tomography/computed tomography imaging accurately detects anatomically and functionally significant coronary artery disease. Circulation. 2010;122:603-613.
19. Brown TL, Merrill J, Volokh L, Bengel FM. Determinants of the response of left ventricular ejection fraction to vasodilator stress in electrocardiographically gated 82rubidium myocardial perfusion PET. Eur J Nucl Med Mol Imaging. 2008;35:336-342.
20. 82Rb PET/CT study. J Nucl Med. 2007;48:349-358.
21. Dorbala S, Hachamovitch R, Curillova Z, et al. Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF. JACC Cardiovasc Imaging. 2009;2:846-854.
22. Trochu JN, Zhao G, Post H, et al. Selective A2A adenosine receptor agonist as a coronary vasodilator in conscious dogs: potential for use in myocardial perfusion imaging. J Cardiovasc Pharmacol. 2003;41:132-139.
23. Gregg DE. Effect of coronary perfusion pressure or coronary flow on oxygen usage of the myocardium. Circ Res. 1963;13:497-500.
24. Cullom SJ, Case JA, Courter SA, McGhie AI, Bateman TM. Regadenoson pharmacologic rubidium-82 PET: a comparison of quantitative perfusion and function to dipyridamole. J Nucl Cardiol. 2012;20:76-83.
25. Ghimire G, Hage FG, Heo J, Iskandrian AE. Regadenoson: a focused update. J Nucl Cardiol. 2013;20:282-288.
26. Partington SL, Lanka V, Hainer J, et al. Safety and feasibility of regadenoson use for suboptimal heart rate response during symptom-limited standard Bruce exercise stress test. J Nucl Cardiol. 2012;19:970-978.
27. Gerber TC, Carr JJ, Arai AE, et al. Ionizing radiation in cardiac imaging: a science advisory from the American Heart Association Committee on Cardiac Imaging of the Council on Clinical Cardiology and Committee on Cardiovascular Imaging and Intervention of the Council on Cardiovascular Radiology and Intervention. Circulation. 2009;119:1056-1065.